4-vinyl-1-cyclohexene dioxide has been researched along with Insulin Sensitivity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anselmo-Franci, JA; Barbosa, AM; Battiston, FG; Dos Santos, C; Leonel, ECR; Lima, FB; Rafacho, A; Sehnem, S; Taboga, SR | 1 |
| Brooks, HL; Diamond-Stanic, MK; Hasty, AH; Hoyer, PB; Romero-Aleshire, MJ | 1 |
2 other study(ies) available for 4-vinyl-1-cyclohexene dioxide and Insulin Sensitivity
| Article | Year |
|---|---|
Glucose homeostasis in rats treated with 4-vinylcyclohexene diepoxide is not worsened by dexamethasone treatment.
Topics: Adipose Tissue; Aging; Animals; Blood Glucose; Cellular Senescence; Cyclohexenes; Dexamethasone; Drug Interactions; Female; Glucocorticoids; Glucose; Glucose Tolerance Test; Glycogen; Homeostasis; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Liver; Ovarian Follicle; Ovary; Primary Ovarian Insufficiency; Rats; Rats, Wistar; Steroids; Vinyl Compounds | 2017 |
Loss of ovarian function in the VCD mouse-model of menopause leads to insulin resistance and a rapid progression into the metabolic syndrome.
Topics: Abdominal Fat; Animals; Blood Glucose; Cholesterol; Cyclohexenes; Dietary Fats; Disease Models, Animal; Disease Progression; Estrogen Replacement Therapy; Fatty Acids, Nonesterified; Female; Insulin; Insulin Resistance; Menopause; Metabolic Syndrome; Mice; Ovary; Primary Ovarian Insufficiency; Time Factors; Vinyl Compounds; Weight Gain | 2009 |